TLDR Hair, skin, and nails supplement use nearly doubled from 2011 to 2020, with higher usage among young adults, females, and certain ethnic groups.
The study analyzed data from the National Health and Nutrition Examination Survey (2011-2020) to examine trends in hair, skin, and nails (HSN) supplement use among 40,959 participants. It found that 3.9% reported past-month HSN supplement use, with higher usage among younger individuals (20-39 years old), females, Black and Hispanic/Latino individuals, and those with more than a high school education. The use of HSN supplements nearly doubled from 2.5% in 2011-2012 to 4.9% in 2017-2020. Despite their popularity, HSN supplements pose significant risks, including biotin interference with medical tests and the presence of heavy metals in some products. The study highlights the need for dermatologists to be aware of these risks and to guide patients accordingly. Limitations include self-reported data and the inability to examine specific supplements or reasons for use.
7 citations,
October 2020 in “Dermatology practical & conceptual” Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.
57 citations,
February 2018 in “Journal of the American Academy of Dermatology” Biotin supplements are not proven to improve hair or nails and may interfere with medical tests.
[object Object]
7 citations,
October 2020 in “Dermatology practical & conceptual” Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.
January 2020 in “Asian journal of applied science and technology” Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.
3 citations,
February 2008 in “Basic and clinical dermatology” Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.
[object Object] 
July 2018 in “Elsevier eBooks” Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.
67 citations,
January 2013 in “Indian Journal of Dermatology, Venereology and Leprology” Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.
